Lower cochlear implant age threshold could improve speech skills -- NIH panel.
This article was originally published in The Gray Sheet
LOWER COCHLEAR IMPLANT MINIMUM AGE THRESHOLD could substantially improve patients' speech and language skills, but evidence currently does not support use in children under two years old, a National Institutes of Health consensus panel concluded at a May 15-17 conference in Bethesda, Maryland. "We would guess as we are looking at the future that the [current] two-year cut-off may change, but right know we don't have enough evidence to say that it should," said panel Chairperson George Gates, University of Washington, at the panel's May 17 press conference.
You may also be interested in...
Approved in February as an on-demand remedy, Nurtec will be filed for migraine prevention after success in Phase III. It could be the first oral preventive therapy and first dual purpose migraine drug.
A protocol amendment is not needed to pause enrollment to decrease potential exposure to COVID-19, and virtual visits can be immediately implemented to ensure safety; experts say pandemic is forcing a rethinking in how companies carry out trials and in how regulators ensure patient safety and trial integrity.
South Korea’s Qurient achieves proof of concept in a Phase II study with its first-in-class antibiotic telacebec for tuberculosis and aims to file a US NDA for the orphan drug.